119 related articles for article (PubMed ID: 759068)
1. Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease--a hypothesis.
McLean A; du Souich P; Gibaldi M
Clin Pharmacol Ther; 1979 Feb; 25(2):161-6. PubMed ID: 759068
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?
Ott P; Clemmesen O; Keiding S
Dig Dis Sci; 2000 Feb; 45(2):359-65. PubMed ID: 10711452
[TBL] [Abstract][Full Text] [Related]
3. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
[TBL] [Abstract][Full Text] [Related]
4. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
Branch RA; James JA; Read AE
Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
[TBL] [Abstract][Full Text] [Related]
5. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
[TBL] [Abstract][Full Text] [Related]
6. Hepatic insufficiency after portacaval shunting is prevented by prior intraportal pancreatic islet autotransplantation.
Callery MP; Ricordi C; Scharp DW; Kamei T; Swanson CJ; Lacy PE; Flye MW
Surgery; 1989 Aug; 106(2):257-65; discussion 265-6. PubMed ID: 2503900
[TBL] [Abstract][Full Text] [Related]
7. Propranolol disposition in chronic liver disease: a physiological approach.
Branch RA; Shand DG
Clin Pharmacokinet; 1976; 1(4):264-79. PubMed ID: 797499
[TBL] [Abstract][Full Text] [Related]
8. The abnormal hepatic scan of chronic liver disease: its relationship to hepatic hemodynamics and colloid extraction.
Horisawa M; Goldstein G; Waxman A; Reynolds T
Gastroenterology; 1976 Aug; 71(2):210-3. PubMed ID: 939379
[TBL] [Abstract][Full Text] [Related]
9. Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog.
Hashimoto N; Ishikawa Y; Utsunomiya J
J Surg Res; 1989 Jan; 46(1):35-40. PubMed ID: 2644488
[TBL] [Abstract][Full Text] [Related]
10. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of end-to-side portacaval shunting and side-to-side mesocaval shunting on hepatic haemodynamics in the dog.
Jenkins SA; Taylor A; Johnson J; Shimirty SK; Baxter JN; Shields R
Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):447-52. PubMed ID: 3757309
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
Kuntz HD; Meessen D; May B
Med Welt; 1982 Jun; 33(25):909-10. PubMed ID: 7109938
[No Abstract] [Full Text] [Related]
13. Effect of portacaval transposition on hepatic function in dogs with obstruction to the hepatic venous outflow.
Baker PR; Shields R
Eur Surg Res; 1975; 7(1):43-52. PubMed ID: 1149762
[TBL] [Abstract][Full Text] [Related]
14. Functional and non-functional liver blood flow in patients with liver cirrhosis measured by indocyanine green.
Perlik F; Janku I; Jedlicka J
Methods Find Exp Clin Pharmacol; 1992; 14(6):459-64. PubMed ID: 1469955
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
Lebrec D; Sicot C; Benhamou JP
Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
[No Abstract] [Full Text] [Related]
16. The rat with portacaval shunt: an animal model with chronic hepatic failure.
Bircher J
Pharmacol Ther B; 1979; 5(1-3):219-22. PubMed ID: 386367
[No Abstract] [Full Text] [Related]
17. Determinants of drug disposition in patients with cirrhosis.
Huet PM; Villeneuve JP
Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the functional reserve of human liver.
Moody FG; Rikkers LF; Aldrete JS
Ann Surg; 1974 Oct; 180(4):592-8. PubMed ID: 4413286
[TBL] [Abstract][Full Text] [Related]
19. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
[TBL] [Abstract][Full Text] [Related]
20. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
Huet PM; Lelorier J
Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
